Natural Products in Diabetes Mellitus: 3rd Edition
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Natural Products".
Deadline for manuscript submissions: 25 May 2026 | Viewed by 880
Special Issue Editor
Interests: nutraceuticals; secondary metabolite; prebiotics; value added
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Diabetes mellitus (DM) is a chronic disease characterized by a state of hyperglycemia. This sustained increase in glucose levels induces oxidative damage, which can contribute in different ways to the development of chronic complications. Such complications have been directly or indirectly related to the high morbidity and mortality of DM. The increase in the prevalence of this disease is more marked in developing countries, although it does not exclude developed countries. Additionally, this disease represents a high cost to the health sector and to the patient. The prevention and control of DM consists of physical activity and diet modification. However, various natural products are used worldwide to aid in the control and prevention of DM.
Natural products come from various sources, such as plants, foods, and microorganisms. They possess or generate bioactive compounds that may have antidiabetic activity, for which the mechanisms of action are diverse and range from the inhibition of enzymes such as alpha-amylase and alpha-glucosidase to the modification of hormonal activities involved in glucose homeostasis. Additionally, natural products can present diverse biological activities that can contribute to or generate synergy in the control and prevention of the predominant complications in DM, by reducing oxidative stress resulting from the increase in free radicals due to the high content of glucose in the blood. Therefore, natural products can contribute to antioxidant enzymatic activity.
However, the use of these natural products is generally part of traditional medicine, so there is not always information to support their use, dosage, toxicity, etc.
The study of the mechanisms of action of various natural products, either in isolation as an active substance or in a more complex form as an extract or in its natural state, is of interest since it provides knowledge for the development of therapeutic agents and adjuvant therapies for DM, in addition to generating information on dosage, toxicity, mechanisms of action, synergistic and/or antagonistic activity, etc.
For this Special Issue, we invite the submission of original contributions, reviews or short communications that contribute to the knowledge of natural products and their antidiabetic action, including either in vivo or in vitro models, therapeutic models, the characterization of compounds and extracts, and mechanisms of action.
Dr. Ana Angelica Feregrino-Perez
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- natural products
- hypoglycemia
- phenolic compounds
- diabetes mellitus
- therapeutic
- ROS
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
